Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Nat Protoc. 2015 Jul 23;10(8):1264–1274. doi: 10.1038/nprot.2015.080

Figure 5.

Figure 5

Differential tumor growth rates and treatment response in orthotopic HCC growing in normal livers versus fibrotic livers. Treatment was given when HCCs were established (7–10 d after intrahepatic HCA-1 cell inoculation). Mice were treated daily by gavage with sorafenib (40 mg/kg) or control vehicle (PBS) alone for 2 weeks. n = 5–13, *P < 0.05. Comparisons between treatment groups were performed using the Mann-Whitney U-test. Adapted with permission from ref. 7.